Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.802,95
-0,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nexmed (MM) (NEXM) Nexmed (MM) (NEXM) Notizie

NEXM

Nexmed (MM) (NEXM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NEXM
DataOraFonteTitoloSimboloCompagnia
10/09/201023:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
10/09/201022:31Business WireNexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus BiosciencesNASDAQ:NEXMNexmed (MM)
31/08/201023:18Edgar (US Regulatory)Securities Registration Statement (S-1)NASDAQ:NEXMNexmed (MM)
25/08/201017:00Business WireNexMed To Present at the Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:NEXMNexmed (MM)
23/08/201015:00Business WireNexMed Receives Additional Patent Coverage for IsraelNASDAQ:NEXMNexmed (MM)
17/08/201012:03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NEXMNexmed (MM)
12/08/201023:10Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
11/08/201015:15Business WireNexMed Announces 2010 Second Quarter Financial Results Conference CallNASDAQ:NEXMNexmed (MM)
06/08/201020:34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NEXMNexmed (MM)
26/07/201018:36Business WireMohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USANASDAQ:NEXMNexmed (MM)
21/06/201015:15GlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.NASDAQ:NEXMNexmed (MM)
15/06/201020:48Business WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
10/06/201019:30Business WireNexMed Provides Update on Canadian Filing for Vitaros®NASDAQ:NEXMNexmed (MM)
27/05/201000:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
25/05/201023:00Business WireNexMed Announces Expansion of Senior Business Development TeamNASDAQ:NEXMNexmed (MM)
17/05/201023:11Business WireNexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDANASDAQ:NEXMNexmed (MM)
12/05/201022:30Business WireNexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound HealingNASDAQ:NEXMNexmed (MM)
10/05/201023:19Business WireNexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...NASDAQ:NEXMNexmed (MM)
07/05/201011:50GlobeNewswire Inc.BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfitNASDAQ:NEXMNexmed (MM)
06/05/201022:45Business WireNexMed Expands Scientific Advisory Board with Appointment of Key Industry LeadersNASDAQ:NEXMNexmed (MM)
05/05/201022:36Business WireNexMed Announces Patent Allowance for NexACT® in CanadaNASDAQ:NEXMNexmed (MM)
30/04/201020:53Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:NEXMNexmed (MM)
29/04/201000:47Business WirePre-Clinical Results Show NexACT® Technology Significantly Improves Subcutaneous Delivery & Anti-Metastatic Activity of Angs...NASDAQ:NEXMNexmed (MM)
27/04/201022:40Business WireNexMed Appoints Dr. Stephen B. Howell, World Renowned Key Opinion Leader in Oncology as Chairman of Its Scientific Advisory B...NASDAQ:NEXMNexmed (MM)
27/04/201014:30MarketwiredMarket Pulse Breaking News Alert for Tuesday, April 27, 2010: MZEI -- Implications of Test Results Are Enormous to Medizone as tNASDAQ:NEXMNexmed (MM)
26/04/201022:45Business WireNexMed Receives FDA Clearance for PrevOnco™ Phase 2 Study as First-Line Therapy for HCCNASDAQ:NEXMNexmed (MM)
23/04/201002:50Business WireNexMed Files CMC Response with Health Canada for Vitaros®NASDAQ:NEXMNexmed (MM)
21/04/201023:24Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NEXMNexmed (MM)
20/04/201012:02Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:NEXMNexmed (MM)
19/04/201012:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:NEXMNexmed (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NEXM

La tua Cronologia

BIT
UC4NHP
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network